In this “Ask the Expert” feature, gynecologic surgeon Dennis Chi discusses why screening for ovarian cancer is not as widespread as it is for certain other cancers.
An international study led by Memorial Sloan-Kettering found that pazopanib (Votrient®) controls cancer as effectively as sunitinib (Sutent®) while improving patients’ quality of life.
Dermatologist Mario Lacouture describes common skin reactions that can develop as a result of cancer treatment and offers tips for lessening their impact.
Memorial Sloan-Kettering’s Resources for Life After Cancer program was created to support cancer survivors in dealing with psychological, physical, and practical issues related to cancer and its treatment.
Deputy Physician-in-Chief for Breast Cancer Programs Larry Norton was interviewed on PBS NewsHour about a recent recommendation from a National Cancer Institute working group that proposed changing the definition of cancer.